Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1001838 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- Aven antibody was raised against a 14 amino acid peptide from near the carboxy terminus of human Aven.
- Description
- Affinity chromatography purified via peptide column.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- 4°C
- Handling
- Antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 myl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container?s cap.
Submitted references Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
Cell death in the third millennium.
Paydas S, Tanriverdi K, Yavuz S, Disel U, Sahin B, Burgut R
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003 Jul;14(7):1045-50
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003 Jul;14(7):1045-50
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
Chau BN, Cheng EH, Kerr DA, Hardwick JM
Molecular cell 2000 Jul;6(1):31-40
Molecular cell 2000 Jul;6(1):31-40
Cell death in the third millennium.
Lockshin RA, Osborne B, Zakeri Z
Cell death and differentiation 2000 Jan;7(1):2-7
Cell death and differentiation 2000 Jan;7(1):2-7
No comments: Submit comment
No validations: Submit validation data